# Ghrelin Effect on Beta Cell Function in Health and Disease

> **NCT01729299** · NA · UNKNOWN · sponsor: **David Dalessio** · enrollment: 30 (estimated)

## Conditions studied

- Diabetes

## Interventions

- **DRUG:** Exendin (9-39)
- **DRUG:** acyl ghrelin
- **DRUG:** saline

## Key facts

- **NCT ID:** NCT01729299
- **Lead sponsor:** David Dalessio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2013-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01729299

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01729299, "Ghrelin Effect on Beta Cell Function in Health and Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01729299. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*